Johnson & Johnson looking to buy eye disease biotech for up to $3.4bn

Drugmaker’s potential acquisition of Ollin Biosciences is latest in glut of deals in biotechnology sector

zeronews247

Drugmaker’s potential acquisition of Ollin Biosciences is latest in glut of deals in biotechnology sector

About the Author

Leave a Reply

Your email address will not be published. Required fields are marked *

About the Author

Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.

BlockSpare — News, Magazine and Blog Addons for (Gutenberg) Block Editor

Search the Archives

Access over the years of investigative journalism and breaking reports